Literature DB >> 23929081

Persistent fetal vasculature: ocular features, management of cataract and outcomes.

Marcia Beatriz Tartarella1, Rodrigo Ueno Takahagi, Ana Paula Braga, João Borges Fortes Filho.   

Abstract

PURPOSES: To describe ocular features, management of cataract and functional outcomes in patients with persistent fetal vasculature.
METHODS: Retrospective, descriptive case series of patients with persistent fetal vasculature. Data were recorded from the Congenital Cataract Section of Federal University of São Paulo, Brazil from 2001 to 2012. All patients were evaluated for sex, age at diagnosis, systemic findings, laterality, age at surgery, and initial and final follow-up visual acuities. Follow-up and complications after cataract surgery were recorded. Ultrasound was performed in all cases and ocular eco-Doppler was performed in most.
RESULTS: The study comprised 53 eyes from 46 patients. Age at diagnosis ranged from 5 days of life to 10 years-old (mean 22.7 months). Twenty-seven patients were male (58.7%). Persistent fetal vasculature was bilateral in 7 patients (15.2%). Forty-two eyes (79.2%) had combined (anterior and posterior forms) PFV presentation, 5 eyes (9.4%) had only anterior persistent fetal vasculature presentation and 6 eyes (11.3%) had posterior persistent fetal vasculature presentation. Thirty-eight eyes (71.7%) were submitted to cataract surgery. Lensectomy combined with anterior vitrectomy was performed in 18 eyes (47.4%). Phacoaspiration with intraocular lens implantation was performed in 15 eyes (39.5%), and without lens implantation in 5 eyes (13.2%). Mean follow-up after surgery was 44 months. Postoperative complications were posterior synechiae (3 cases), retinal detachment (2 cases), phthisis (3 cases), posterior capsular opacification (8 cases), inflammatory pupillary membrane (5 cases), glaucoma (4 cases), intraocular lens implantation displacement (1 case) and vitreous hemorrhage (2 cases). Complications were identified in 19 (50%) of the 38 operated eyes. Visual acuity improved after cataract surgery in 83% of the eyes.
CONCLUSIONS: Patients with persistent fetal vasculature have variable clinical presentation. There is an association of persistent fetal vasculature with congenital cataract. Severe complications are related to cataract surgery in patients with persistent fetal vasculature, but 83% of the operated eyes improved visual acuity.

Entities:  

Mesh:

Year:  2013        PMID: 23929081     DOI: 10.1590/s0004-27492013000300011

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  6 in total

1.  Salmon pink patch sign: Diagnosing persistent fetal vasculature.

Authors:  Sudarshan Khokhar; Shikha Gupta; Varun Gogia; Bhagabat Nayak
Journal:  Oman J Ophthalmol       Date:  2016 Jan-Apr

Review 2.  Ocular ultrasonography focused on the posterior eye segment: what radiologists should know.

Authors:  Marcela De La Hoz Polo; Anna Torramilans Lluís; Oscar Pozuelo Segura; Albert Anguera Bosque; Catalina Esmerado Appiani; Josep Maria Caminal Mitjana
Journal:  Insights Imaging       Date:  2016-02-24

3.  Congenital fibrovascular pupillary membrane.

Authors:  Mauro Waiswol; Fábio Ejzenbaum; Davi Chen Wu; Eduardo Kagohara; José Ricardo de Abreu Reggi
Journal:  Einstein (Sao Paulo)       Date:  2015-03-03

4.  Unilateral anterior persistent fetal vasculature in a child with blepharophimosis-ptosis-epicanthus inversus syndrome: A surgical challenge.

Authors:  Vasudha Kemmanu; Pragnya Rathod; Hemant Anaspure; Naresh K Yadav
Journal:  Indian J Ophthalmol       Date:  2016-06       Impact factor: 1.848

5.  Outcomes and surgical management of persistent fetal vasculature.

Authors:  Nikhila Khandwala; Cagri Besirli; Brenda L Bohnsack
Journal:  BMJ Open Ophthalmol       Date:  2021-04-29

6.  Clinical Characteristics and Surgical Safety in Congenital Cataract Eyes with Three Pathological Types of Posterior Capsule Abnormalities.

Authors:  Xixia Ding; Linfeng Xiang; Qianwei Wang; Dandan Wang; Pingjun Chang; Zhangliang Li; Yinying Zhao; Feixue Chu; Chao Ma; Yun-E Zhao
Journal:  J Ophthalmol       Date:  2020-03-16       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.